Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Gary Deng, MD, Memorial Sloan Kettering Cancer Center

Videos

Complementary Medicine for Patients With Gastrointestinal Malignancies

12/20/2022

At the 2022 Great Debates & Updates in Gastrointestinal Malignancies virtual meeting, Gary Deng, MD, discusses modes of complementary medicine that patients with gastrointestinal cancers may be curious about.

At the 2022 Great Debates &...

12/20/2022

Oncology

Quiz

Quiz: Optimal Timing for Palliative Care in Gastrointestinal Cancers

11/30/2022

When should palliative care be initiated in the treatment of a patients with gastrointestinal malignancies?

When should palliative care be...

11/30/2022

Oncology

Rajiv Agarwal, MD, Vanderbilt University, Medical Center

Videos

Providing Palliative Care for Patients With Gastrointestinal Cancers

11/21/2022

Rajiv Agarwal, MD, discusses how to best provide palliative care for patients with gastrointestinal cancers, a topic he presented at the 2022 Great Debates and Updates in Gastrointestinal Malignancies virtual meeting.

Rajiv Agarwal, MD, discusses how...

11/21/2022

Oncology

Ghassan Abou-Alfa, MD, Memorial Sloan Kettering

Videos

Tremelimumab Plus Durvalumab Receives FDA Approval for Unresectable Hepatocellular Carcinoma

11/21/2022

Ghassan Abou-Alfa, MD, shares insights about the recent FDA approval of tremelimumab plus durvalumab for patients with unresectable hepatocellular carcinoma and discusses findings from the HIMALAYA trial, which led to the approval.

Ghassan Abou-Alfa, MD, shares...

11/21/2022

Oncology

Alvaro Arjona-Sanchez, MD, Hospital Universitario Reina Sofia

Videos

Adjuvant HIPEC Before Resection Improves Locoregional Control in Patients With Locally Advanced Colon Cancer

11/14/2022

Alvaro Arjona-Sanchez, MD, explains findings from a phase 3 studyshowing HIPEC combined with mitomycin C, administered prior to surgical resection for locally advanced colon cancer, led to an improvement in locoregional control rate.

Alvaro Arjona-Sanchez, MD,...

11/14/2022

Oncology

Joseph Chao, MD, City of Hope Comprehensive Cancer Center

Videos

New and Targeted Therapy for Gastric Cancer: A Focus on Immunotherapy and HER2

09/29/2022

Joseph Chao, MD, reviews his presentation on new and upcoming targeted agents in gastric cancer from the Great Debates and Updates in Gastrointestinal Malignancies virtual meeting in September 2022.

Joseph Chao, MD, reviews his...

09/29/2022

Oncology

Arndt Vogel, MD, Medizinische Hochschule Hannover

Sponsored

Videos

Pemigatinib for Locally Advanced or Metastatic Cholangiocarcinoma: FIGHT-202 Trial

08/25/2022

Michel Ducreux, MD, PhD, and Arndt Vogel, MD, discuss results from the phase 2 FIGHT-202 trial, which evaluated the efficacy and safety of pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma.

Michel Ducreux, MD, PhD, and...

08/25/2022

Oncology

Ignacio Garrido-Laguna, MD, Huntsman Cancer Institute

Videos

Entrectinib Yields Durable Responses, Manageable Safety in NTRK Fusion-Positive Gastrointestinal Cancers

07/03/2022

Ignacio Garrido-Laguna, MD, discusses findings from an updated integrated analysis exploring entrectinib in patients with NTRK fusion-positive gastrointestinal cancer.

Ignacio Garrido-Laguna, MD,...

07/03/2022

Oncology

Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center

Videos

Overlap Between HER2 and PD-L1 Expression in Trastuzumab-Refractory Gastric Cancer or GEJ Adenocarcinoma

07/02/2022

Yelena Janjigian, MD, discusses findings from a preliminary biomarker analysis of the ongoing DESTINY-Gastric03 trial, which explored concordance between local and central HER2 testing and overlap of PD-L1 and HER2 expression in gastric...

Yelena Janjigian, MD, discusses...

07/02/2022

Oncology

Andrea Casadei-Gardini, MD, San Raffaele Hospital

Videos

Lenvatinib Demonstrates Significant Benefit vs Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma

07/02/2022

Andrea Casadei-Gardini, MD, discusses findings from an international study examining atezolizumab plus bevacizumab vs lenvatinib or sorafenib in patients with non-viral unresectable hepatocellular carcinoma.

Andrea Casadei-Gardini, MD,...

07/02/2022

Oncology

Section Editor

Ghassan Abou-Alfa, MD, MBA

Memorial Sloan Kettering Cancer Center, New York

Gastrointestinal Cancer Excellence Forum

Section Editor

Resources

Specialties

Events

Year Round Education

HMP Global Products